OAM
FPRX

Oxford Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Oxford Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-294,379
Closed -$1.35M – 1634
2019
Q4 		$1.35M Buy
294,379
+1,173
+0.4% +$4.65K 0.04% 663
2019
Q3 		$1.14M Sell
293,206
-408
-0.1% -$2.24K 0.03% 877
2019
Q2 		$1.77M Buy
293,614
+108,766
+59% +$1.04M 0.04% 695
2019
Q1 		$2.48M Sell
184,848
-100,389
-35% -$1.15M 0.05% 474
2018
Q4 		$2.65M Sell
285,237
-11,102
-4% -$132K 0.07% 345
2018
Q3 		$4.13M Buy
296,339
+254,916
+615% +$3.79M 0.09% 285
2018
Q2 		$650K Buy
+41,423
New +$723K 0.01% 1236
2017
Q3 		– Sell
-10,565
Closed -$318K – 1782
2017
Q2 		$318K Sell
10,565
-26,796
-72% -$836K 0.01% 1245
2017
Q1 		$1.35M Sell
37,361
-31,465
-46% -$1.39M 0.03% 688
2016
Q4 		$3.45M Buy
68,826
+15,678
+29% +$824K 0.12% 168
2016
Q3 		$2.79M Sell
53,148
-51,054
-49% -$2.44M 0.09% 320
2016
Q2 		$4.31M Sell
104,202
-32,541
-24% -$1.42M 0.14% 179
2016
Q1 		$5.56M Buy
136,743
+106,901
+358% +$3.67M 0.16% 140
2015
Q4 		$1.24M Buy
+29,842
New +$1M 0.03% 484

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Oxford Asset Management's FPRX Position: Q1 2020 in Review

Oxford Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 294,379 shares — an estimated $1.35M sold.

Oxford Asset Management first reported a position in FPRX in Q4 2015 and held it in 14 quarters. The position peaked at $5.56M in Q1 2016. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

  • Oxford Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 294,379 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $1.35M.
  • Oxford Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 14 quarters.
  • Oxford Asset Management's Five Prime Therapeutics, Inc. position peaked at $5.56M in Q1 2016.
  • 87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.